Human Neprilysin DuoSet ELISA, 15 Plate Summary
Source
N/A
Assay Type
Solid Phase Sandwich ELISA
Inter-Assay
Intra-Assay
Spike Recovery
Sample Volume
Gene
MME
Applications/Dilutions
Dilutions
Application Notes
No significant interference observed with available related molecules.
Publications
Packaging, Storage & Formulations
Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Human Neprilysin DuoSet ELISA, 15 Plate
Background
The neprilysin (NEP) family of zinc metallopeptidases includes neprilysin, endothelin-converting enzyme-2 (ECE-2), PEX, damage induced neuronal endopeptidase (DINE), Kell and several neprilysin-like proteins. Neprilysin is expressed at the cell surface of a variety of cell types. Enzymatically, neprilysin functions both as an endopeptidase with a thermolysin-like specificity and as a dipeptidylcarboxypeptidase. Neprilysin has been shown to be involved in the degradation of enkephalins in the mammalian brain and the inactivation of circulating atrial natriuretic peptide. Neprilysin has also been identified as the common acute lymphoblastic leukemia antigen (CALLA), and to be expressed on the surface of lymphocytes in some disease states. These and other observations have resulted in considerable clinical interest in neprilysin as a potential target for analgesics and antihypertensive drugs. Neprilysin is also a major degrading enzyme of amyloid-beta peptide (A-beta) in the brain, indicating that down-regulation of neprilysin activity, which could be caused by aging, can contribute to the development of Alzheimers disease by promoting A-beta accumulation.
Customers Who Viewed This Item Also Viewed...
Species: Mu
Applications: CyTOF-ready, Flow, IHC, IP, Simple Western, WB
Species: Hu, Rt
Applications: Flow, ICC/IF, IHC, IHC-P, IP, WB
Species: Hu, Mu, Rt
Applications: IHC
Species: Hu, Mu
Applications: Flow, WB
Species: Mu
Applications: CyTOF-ready, Flow, ICC, IHC, IP, WB
Species: Hu, Mu
Applications: CyTOF-ready, Flow, ICC/IF, In vitro, WB
Species: Hu
Applications: BA
Species: Hu
Applications: CyTOF-ready, ELISA, Flow, ICC/IF, IHC, IHC-P, PA, WB
Species: Hu, Mu
Applications: Flow-IC, Flow, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WB
Species: Hu
Applications: ICC/IF, IHC, IHC-P
Species: Ca, Hu, Mu, Rt
Applications: IHC, IHC-P, IP, WB
Species: Hu
Applications: CyTOF-ready, Flow, IMC, ICC/IF, IHC, IHC-P, WB
Species: Rt
Applications: IHC, WB
Species: Hu, Mu, Rt
Applications: IHC, IHC-P, WB
Species: Hu
Applications: IHC, IHC-P, WB
Species: Hu, Mu
Applications: IHC, IHC-P, WB
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, WB
Species: Ba, Hu, Pm, Mu, Rt
Applications: DB, ELISA, IB, ICC/IF, IHC-FrFl, IHC, IHC-Fr, IHC-P, IP, WB
Publications for Neprilysin/CD10 (DY1182)(8)
We have publications tested in 1 confirmed species: Human.
Submit a Publication
Filter By Application
All Applications
Filter By Species
All Species
Showing Publications 1 -
8 of 8.
Publications using DY1182
Applications
Species
S Prausmülle, H Arfsten, G Spinka, C Freitag, PE Bartko, G Goliasch, G Strunk, N Pavo, M Hülsmann Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF J Am Heart Assoc, 2020-05-19;9(11):e015071. 2020-05-19 [PMID: 32427034] (Human)
Human
N Pavo, H Arfsten, A Cho, G Goliasch, PE Bartko, R Wurm, C Freitag, H Gisslinger, G Kornek, G Strunk, M Raderer, C Zielinski, M Hülsmann The circulating form of neprilysin is not a general biomarker for overall survival in treatment-na�ve cancer patients Sci Rep, 2019-02-22;9(1):2554. 2019-02-22 [PMID: 30796257] (Human)
Human
C Klein, G Roussel, S Brun, C Rusu, C Patte-Mens, M Maitre, AG Mensah-Nya 5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer's disease Acta Neuropathol Commun, 2018-12-11;6(1):136. 2018-12-11 [PMID: 30537985] (Human)
Human
H Bernelin, N Mewton, S Si-Mohamed, P Croisille, G Rioufol, E Bonnefoy-C, P Douek, N Dufay, C Amaz, C Jossan, M Ovize, T Bochaton Neprilysin levels at the acute phase of ST-elevation myocardial infarction Clin Cardiol, 2018-12-10;0(0):. 2018-12-10 [PMID: 30284298] (Human)
Human
SS Zaidi, RD Ward, K Ramanathan, X Yu, IP Gladysheva, GL Reed Possible Enzymatic Downregulation of the Natriuretic Peptide System in Patients with Reduced Systolic Function and Heart Failure: A Pilot Study Biomed Res Int, 2018-07-26;2018(0):7279036. 2018-07-26 [PMID: 30148170] (Human)
Human
Miners JS, van Helmond Z, Kehoe PG, Love S Changes with age in the activities of beta-secretase and the Abeta-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme. Brain Pathol., 2010-01-12;20(4):794-802. 2010-01-12 [PMID: 20175776] (Human)
Human
Kuniyasu H, Luo Y, Fujii K, Sasahira T, Moriwaka Y, Tatsumoto N, Sasaki T, Yamashita Y, Ohmori H CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver. Gut, 2009-10-14;59(3):348-56. 2009-10-14 [PMID: 19828468] (Human)
Human
Miners JS, Verbeek MM, Rikkert MO, Kehoe PG, Love S Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid. J. Neurosci. Methods, 2007-08-25;167(2):229-36. 2007-08-25 [PMID: 17904641] (Human)
Human
Reviews for Neprilysin/CD10 (DY1182) (0)
There are no reviews for Neprilysin/CD10 (DY1182).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
FAQs for Neprilysin/CD10 (DY1182) (0)
Additional Neprilysin/CD10 Products
Blogs on Neprilysin/CD10